June 11 (Reuters) – Drug wholesaler Pharmsource LLC said it was unaware the Dexcom glucose sensors it bought from licensed distributors had been slated for destruction, after the device maker warned some units were stolen during disposal and resold.
Here are some details:
• Dexcom warned users in May that two lots of its G7 continuous glucose monitoring sensors were stolen during a destruction process and later sold by third parties, with the company tracing some of those sales to Pharmsource.
• Brunswick, Georgia-based Pharmsource said it had immediately conducted a thorough audit of its inventory and implemented remedial measures.
• “Pharmsource had zero involvement in Dexcom’s destruction process, which is where Dexcom reports the theft occurred,” a company spokesperson told Reuters, adding it would assist authorities in their investigation.
• Dexcom had said one of the affected lots may carry an increased risk of skin infection, while the other has a higher likelihood of producing no readings.
• The device maker did not immediately respond to a request for comment on the Pharmsource statement outside business hours.
(Reporting by Mariam Sunny in Bengaluru; Editing by Vijay Kishore)
